Company profile

Polaris Group

6550 · TWSE (Taiwanese biopharmaceutical company (ADI-PEG 20), listed on the Taiwan Stock Exchange since 6 June 2022 — NOT Polaris Inc. the US powersports maker (PII), which an automated name match wrongly proposed. [resolved 2026-08-05 by resolve-null-is-public; source: https://polarispharma.com/2022/06/07/2022060601/?lang=en]) · Taiwan

Public Market Listing

6550TWSE

TWSE primary exchange listing

Live quotes, historical charts, and market capitalization for Polaris Group are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(1 total)

1Total Assets

0Approved

1Phase 3 / Filed

0Phase 1–2 / Early

1Diseases

Showing 1 of 1 assets

		Target & Modality
Pegargiminase	Phase 3	Arginine-depleting pegylated arginine deiminaseSmall molecule	Acute Myeloid Leukemia

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.